Vertera Spine company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

verteraspine.com

Stage

Acquired | Acquired

Total Raised

$3.24M

About Vertera Spine

Vertera Spine is a medical device company that develops and commercializes multifunctional implants that use or complement its patented porous technology to address critical clinical needs in spine surgery. The company has received funding from the National Science Foundation, Georgia Research Alliance, and Duke Angel Network to translate its growing technology portfolio into commercial products.

Vertera Spine Headquarter Location

739 Trabert Ave NW Suite F

Atlanta, Georgia, 30318,

United States

571-758-3783

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vertera Spine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vertera Spine is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

10,998 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Vertera Spine Patents

Vertera Spine has filed 27 patents.

The 3 most popular patent topics include:

  • Polymers
  • Chromatography
  • Thermoplastics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/29/2019

4/12/2022

Polymers, Thermoplastics, Biomaterials, Organic polymers, Chromatography

Grant

Application Date

7/29/2019

Grant Date

4/12/2022

Title

Related Topics

Polymers, Thermoplastics, Biomaterials, Organic polymers, Chromatography

Status

Grant

Latest Vertera Spine News

Vertera Spine secures FDA clearance for Coalesce lumbar interbody fusion device

Oct 18, 2017

Vertera Spine secures FDA clearance for Coalesce lumbar interbody fusion device Vertera Spine has secured an approval from the US Food and Drug Administration (FDA) for its Coalesce lumbar interbody fusion device. The approval is for using the device in anterior, transforaminal, posterior, and lateral lumbar interbody fusion procedures. According to Vertera Spine, Coalesce features its novel proprietary porous PEEK biomaterial. It has now become the second porous PEEK device to get FDA approval after the company’s Cohere cervical interbody fusion device. Vertera Spine CEO Chris Lee said: "Based on the initial success with the COHERE Cervical porous PEEK device, we saw the need to apply this innovative technology to other spine applications. "We are pleased to have received FDA clearance for COALESCE and look forward to further serving surgeons' clinical demands for a durable fusion device that successfully osseointegrates and allows for integration to be assessed on imaging." Coalesce is expected to be launched for TLIF and PLIF procedures in multiple footprint, height, and lordotic angle configurations in due course of the year. Coalesce leverages on the osseointegration capabilities of porous metal implants and combines them with the favorable imaging and mechanical properties of conventional PEEK implants. In contrast to metal-coated PEEK implants that are prone to delaminate, Coalesce’s PEEK architecture is grown directly out of the solid PEEK base of the implant. It also has an interfacial strength that is comparatively more than the shear strength of vertebral trabecular bone. Also, when compared to 3D-printed metal implants, porous PEEK is mechanically similar to bone under compression. Thereby, it essentially removes any stress shielding effects, and does not create any imaging artifacts to allow for accurate visual assessment of fusion. Image: The FDA Laboratory Building 62 in Silver Spring, Maryland which houses the Center for Devices and Radiological Health. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org. Share:

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.